Search results for "Complementary"

showing 10 items of 1156 documents

Activity of Cordycepin From Cordyceps sinensis Against Drug-Resistant Tumor Cells as Determined by Gene Expression and Drug Sensitivity Profiling

2021

Cordycepin is one of the substantial components of the parasitic fungus Cordyceps sinensis as well as other Cordyceps species. It exerts various effects such as antimetastatic, antiinflammatory, antioxidant, and neuroprotective activities. Assorted studies revealed in vitro and in vivo anticancer influence of cordycepin and put forward its potential for cancer therapy. However, the role of multidrug resistance-associated mechanisms for the antitumor effect of cordycepin has not been investigated in great detail thus far. Therefore, we searched cordycepin’s cytotoxicity with regard to well-known anticancer drug resistance mechanisms, including ABCB1, ABCB5, ABCC1, ABCG2, EGFR, and TP53, and…

PharmacologyDrug0303 health sciencesCordycepsCordycepinbiologymedia_common.quotation_subjectATP-binding cassette transporterPlant ScienceGeneral MedicineDrug resistanceFungusPharmacologybiology.organism_classificationTranscriptome03 medical and health scienceschemistry.chemical_compound0302 clinical medicineComplementary and alternative medicinechemistry030220 oncology & carcinogenesisDrug DiscoveryGene expression030304 developmental biologymedia_commonNatural Product Communications
researchProduct

Cytotoxicity of main anthraquinone aglycons towards drug sensitive and multi drug resistant T leukaemia cancer cells

2016

PharmacologyDrugChemistrymedia_common.quotation_subjectOrganic ChemistryPharmaceutical ScienceAnthraquinoneAnalytical Chemistrychemistry.chemical_compoundComplementary and alternative medicineDrug DiscoveryCancer cellCancer researchMolecular MedicineMulti drug resistantCytotoxicitymedia_commonPlanta Medica
researchProduct

Elsholtzia blandaBenth: New Citral-rich Chemotypes from India

2012

The essential oils of the previously un-investigated aerial parts of Elsholtzia blanda were analyzed by GC and GC/MS. The yields of the oil were found to be 0.93 and 1.70% on fresh weight basis. A total of 25 compounds, representing 82.8% and 87.9% of the oil, were identified. The main compounds were geranial (43.5%–48.8%), neral (31.7%–34.7%), E-isocitral (1.2%–0.1%), and caryophyllene oxide (1.6%–0.7%). These two cultivars have the potential to compete with commercial citral oils.

PharmacologyElsholtzia blandabiologyChemotypeChemistryFresh weightbiology.organism_classificationCitrallaw.inventionHorticulturechemistry.chemical_compoundComplementary and alternative medicineCaryophyllene oxidelawBotanyLamiaceaeCultivarEssential oilJournal of Herbs, Spices & Medicinal Plants
researchProduct

Mikrobiologische C-17-Oxidation von Clavinalkaloiden

1984

PharmacologyElymoclavineAlkaloidOrganic ChemistryClavine AlkaloidsPharmaceutical ScienceAnalytical Chemistrychemistry.chemical_compoundComplementary and alternative medicinechemistryBiotransformationDrug DiscoveryClaviceps paspaliMolecular MedicineOrganic chemistryPlanta Medica
researchProduct

The Cytotoxic Properties of Natural Coumarins Isolated from Roots ofFerulago campestris(Apiaceae) and of Synthetic Ester Derivatives of Aegelinol

2009

Grandivittin (1), agasyllin (2), aegelinol benzoate (3) and felamidin (20), four natural coumarins isolated from Ferulago campestris, and several synthetic ester derivatives of aegelinol (4) were tested against four tumor cell lines. Some of them were shown to be marginally cytotoxic against the A549 lung cancer cell line.

PharmacologyEster derivativesfood.ingredientApiaceaeStereochemistryPlant compositionPlant ScienceGeneral MedicineBiologybiology.organism_classificationFerulago campestrisFerulagofoodComplementary and alternative medicineDrug DiscoveryCytotoxic T cellOrganic chemistryNatural Product Communications
researchProduct

Flavone Glycosides of Sideritis incana

1986

PharmacologyFlavone glycosidesComplementary and alternative medicineTraditional medicineSideritis incanaOrganic ChemistryDrug DiscoveryPharmaceutical ScienceMolecular MedicineBiologyAnalytical ChemistryPlanta Medica
researchProduct

Flavonoids fromAlphitonia neocaledonica

1995

PharmacologyFolk medicineNouvelle caledoniebiologyTraditional medicineOrganic ChemistryPharmaceutical SciencePharmacognosybiology.organism_classificationAnalytical ChemistryAlphitonia neocaledonicaComplementary and alternative medicineDrug DiscoveryRhamnaceaeBotanyMolecular MedicinePlanta Medica
researchProduct

Flavonoids ofRhamnus lycioides; Part 2

1988

PharmacologyFolk medicineTraditional medicinebiologyChemistryOrganic ChemistryRhamnus lycioidesPharmaceutical ScienceEriodictyolbiology.organism_classificationAnalytical Chemistrychemistry.chemical_compoundComplementary and alternative medicineDrug DiscoveryMolecular MedicinePlanta Medica
researchProduct

Nanoscale delivery of phytochemicals targeting CRISPR/Cas9 for cancer therapy.

2021

Abstract Background With growing global prevalence, cancer is a major cause of disease-related deaths. The understanding of the fundamental tumor pathology has contributed to the development of agents targeting oncogenic signaling pathways. Although these agents have increased survival for defined cancers, the therapeutic choices are still limited due to the development of drug resistance. CRISPR/Cas9 is a powerful new technology in cancer therapy by facilitating the identification of novel treatment targets and development of cell-based treatment strategies. Purpose We focused on applications of the CRISPR/Cas9 system in cancer therapy and discuss nanoscale delivery of cytotoxic phytochemi…

PharmacologyGene Editingbusiness.industryCas9PhytochemicalsCancer therapyPharmaceutical ScienceCancerDrug resistanceComputational biologymedicine.diseaseTumor PathologyGenome engineeringComplementary and alternative medicineGenome editingNeoplasmsDrug DiscoverymedicineMolecular MedicineCRISPRHumansCRISPR-Cas SystemsbusinessPhytomedicine : international journal of phytotherapy and phytopharmacology
researchProduct

Shikonin reduces the tumour formation and IL-17 in a model of colorectal cancer associated to chronic colitis in C57BL/6 mice

2016

PharmacologyGerontologyC57BL/6biologybusiness.industryColorectal cancerOrganic ChemistryPharmaceutical Sciencemedicine.diseasebiology.organism_classificationTumor formationAnalytical ChemistryComplementary and alternative medicineDrug DiscoveryCancer researchMolecular MedicineMedicineInterleukin 17businessChronic colitisPlanta Medica
researchProduct